About Holoclara
Holoclara is a Healthcare company based in Los Angeles (United States) founded in 2017 by Andrea Choe. Worm-derived therapies for allergic and autoimmune diseases are developed. Holoclara has raised $16 million across 3 funding rounds from investors including HHS, Bold Capital Partners and Horizons Ventures. Its chief executive, as recorded, is Andrea Choe. Holoclara offers products and services including Worm-based Health Solutions and Health Research Offerings. Its focus areas include Healthcare Projects. Its legal entity is Holoclara Inc.
Company details
Holoclara was established in 2017 in Los Angeles, United States, with Andrea Choe serving as founder and CEO. Operations center on biotechnology, where therapies sourced from worms are researched and developed to address allergic and autoimmune conditions. The focus remains on advancing treatments through this specialized approach, targeting disease management in the healthcare sector.
- Headquarters Los Angeles, United States
- Founders Andrea Choe
- SectorsHealthcare
- Website holoclara.com
- Legal Name Holoclara Inc
- Total Equity Funding$16M (USD)
in 3 rounds
- Latest Funding Round$16M (USD), Series A
Jun 2024
- InvestorsHHS
& 7 more
Products & Services of Holoclara
Holoclara offers a comprehensive portfolio of products and services, including Worm-based Health Solutions and Health Research Offerings.
Human health and aging are addressed through worm-based innovations that are developed by HOLOCLARA.
Research on transforming human health and aging is conducted by HOLOCLARA using specified methodologies.
Funding Insights of Holoclara
Holoclara has successfully raised a total of $16M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $16 million completed in June 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $16M
- Total Rounds 3
- Last Round Series A — $16M
- Investors Count 8
All 3 funding rounds of Holoclara with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2024 | $16M | Series A | – | Bold Capital Partners | |
| Apr 2023 | $258,996 | Grant | – | – | |
| May 2017 | Seed | – | – |
8 investors in total: 8 institutional.
Investors in Holoclara
Holoclara has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, Bold Capital Partners and Horizons Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage life sciences and tech focused VC firm investing primarily in the US | boldcapitalpartners.com | Santa Monica, United States | ||
Horizons Ventures is focused on investing in deep science and technology. | horizonsventures.com | Hong Kong, China | ||
Tech startups are accelerated and incubated by FreeFlow. | freeflow.zone | Kolkata, India | ||
Endurance28 is focused on empowering entrepreneurs with innovative solutions. | endurance28.com | San Francisco, United States | ||
Early-stage venture capital investments in deep tech health solutions are provided by Freeflow. | 2019 | freeflow.io | Berkeley, United States | |
Venture capital firm focused on life sciences, physical sciences, and technology companies | kairosventures.com | Beverly Hills, United States | ||
| tarrasque.tcc.mode | ||||
Public health and human services are overseen by HHS. | 1953 | hhs.gov |
Investor details for Holoclara
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Holoclara
6 people are tracked at Holoclara (4 in leadership, 2 in team).
| Name | Role | Group |
|---|---|---|
Andrea Choe | Founder & CEO | Leadership |
Oliver Loson | VP Of Business Operations | Leadership |
Hung Nguyen | Vice President Of Preclinical Development | Leadership |
Mariana Uchoa | Director Of Immunology | Leadership |
Sarah Torres | Executive Assistant | Team |
Nicholas Everetts | Computational Biologist | Team |
Complete people profiles for Holoclara
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Holoclara
3 dated milestones of Holoclara across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Holoclara is founded.
- Funding First funding round.
- Funding Latest funding round, Series A, of $16.0M.
Web traffic of Holoclara
The website of Holoclara (holoclara.com) receives about 2K visits a month.
- Monthly visits2K
▲ 50.8% vs previous month
Top companies in Healthcare Associations & Projects
3 companies that operate in the same segment as Holoclara (Healthcare Associations & Projects) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provider of maternal and infant health support services. This organization supports research, education, and advocacy efforts to improve maternal a... | 1938 | United States | ||||
Association focused on improving global health through compounding, biologics, pharmaceutical manufacturing | 1820 | Rockville, Maryland, United States | USD 14.1 M | |||
Foundation focused on enhancing wellness and support for medical education | 1940 | United States | USD 320.14 K |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Holoclara
Holoclara was founded in 2017.
Holoclara is headquartered in Los Angeles, United States. It is registered at Los Angeles, California, United States.
Andrea Choe is the CEO of Holoclara, as recorded in our data. They have also founded this company.
Holoclara is a funded company, having raised a total of $16M across 3 funding rounds to date.
Holoclara was established in 2017 in Los Angeles, United States, with Andrea Choe serving as founder and CEO. Operations center on biotechnology, where therapies sourced from worms are researched and developed to address allergic and autoimmune conditions. The focus remains on advancing treatments through this specialized approach, targeting disease management in the healthcare sector.
Holoclara offers Worm-based Health Solutions and Health Research Offerings.
Holoclara has 8 investors. Key investors include HHS, Bold Capital Partners, Horizons Ventures, FreeFlow Ventures, and Tarrasque.
Holoclara operates through Holoclara Inc.